The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Healthcare CMO Market Research Report 2025

Global Healthcare CMO Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1892777

No of Pages : 81

Synopsis

Industry and government regulations have forced enterprises to outsource manufacturing operations to the third party to remain competitive and enhance business process efficiency. Increasing investment in the healthcare sector has also provided the necessary impetus to the market.

The global Healthcare CMO market was valued at US$ 80480 million in 2023 and is anticipated to reach US$ 160510 million by 2030, witnessing a CAGR of 9.9% during the forecast period 2024-2030.

North American market for Healthcare CMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Healthcare CMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Healthcare CMO in Pharmaceutical is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Healthcare CMO include Accellent, Boehringer Ingelheim, Catalent, DSM, Fareva, Greatbatch, Lonza, Patheon and Piramal, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Healthcare CMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Healthcare CMO.

Report Scope

The Healthcare CMO market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Healthcare CMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Healthcare CMO companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company (Partial List):

  • Accellent
  • Boehringer Ingelheim
  • Catalent
  • DSM
  • Fareva
  • Greatbatch
  • Lonza
  • Patheon
  • Piramal
  • Tecomet

Segment by Type

  • Pharmaceutical Contract Manufacturing Services (Active Pharmaceutical Ingredients (API) Manufacturing, Final Dosage Form (FDF) Manufacturing, and Packaging)
  • Medical Device Contract Manufacturing Services (Outsourcing Design, Device Manufacturing (Material Process Services, Electronic Manufacturing Services, and Finished Products), and Final Goods Assembly)
  • Final Goods Assembly

Segment by Application

  • Pharmaceutical
  • Biotechnology Industry

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Healthcare CMO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Healthcare CMO Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Pharmaceutical Contract Manufacturing Services (Active Pharmaceutical Ingredients (API) Manufacturing, Final Dosage Form (FDF) Manufacturing, and Packaging)
1.2.3 Medical Device Contract Manufacturing Services (Outsourcing Design, Device Manufacturing (Material Process Services, Electronic Manufacturing Services, and Finished Products), and Final Goods Assembly)
1.2.4 Final Goods Assembly
1.3 Market by Application
1.3.1 Global Healthcare CMO Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical
1.3.3 Biotechnology Industry
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Healthcare CMO Market Perspective (2019-2030)
2.2 Healthcare CMO Growth Trends by Region
2.2.1 Global Healthcare CMO Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Healthcare CMO Historic Market Size by Region (2019-2024)
2.2.3 Healthcare CMO Forecasted Market Size by Region (2025-2030)
2.3 Healthcare CMO Market Dynamics
2.3.1 Healthcare CMO Industry Trends
2.3.2 Healthcare CMO Market Drivers
2.3.3 Healthcare CMO Market Challenges
2.3.4 Healthcare CMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Healthcare CMO Players by Revenue
3.1.1 Global Top Healthcare CMO Players by Revenue (2019-2024)
3.1.2 Global Healthcare CMO Revenue Market Share by Players (2019-2024)
3.2 Global Healthcare CMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Healthcare CMO Revenue
3.4 Global Healthcare CMO Market Concentration Ratio
3.4.1 Global Healthcare CMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Healthcare CMO Revenue in 2023
3.5 Healthcare CMO Key Players Head office and Area Served
3.6 Key Players Healthcare CMO Product Solution and Service
3.7 Date of Enter into Healthcare CMO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Healthcare CMO Breakdown Data by Type
4.1 Global Healthcare CMO Historic Market Size by Type (2019-2024)
4.2 Global Healthcare CMO Forecasted Market Size by Type (2025-2030)
5 Healthcare CMO Breakdown Data by Application
5.1 Global Healthcare CMO Historic Market Size by Application (2019-2024)
5.2 Global Healthcare CMO Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Healthcare CMO Market Size (2019-2030)
6.2 North America Healthcare CMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Healthcare CMO Market Size by Country (2019-2024)
6.4 North America Healthcare CMO Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Healthcare CMO Market Size (2019-2030)
7.2 Europe Healthcare CMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Healthcare CMO Market Size by Country (2019-2024)
7.4 Europe Healthcare CMO Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Healthcare CMO Market Size (2019-2030)
8.2 Asia-Pacific Healthcare CMO Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Healthcare CMO Market Size by Region (2019-2024)
8.4 Asia-Pacific Healthcare CMO Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Healthcare CMO Market Size (2019-2030)
9.2 Latin America Healthcare CMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Healthcare CMO Market Size by Country (2019-2024)
9.4 Latin America Healthcare CMO Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Healthcare CMO Market Size (2019-2030)
10.2 Middle East & Africa Healthcare CMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Healthcare CMO Market Size by Country (2019-2024)
10.4 Middle East & Africa Healthcare CMO Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Accellent
11.1.1 Accellent Company Detail
11.1.2 Accellent Business Overview
11.1.3 Accellent Healthcare CMO Introduction
11.1.4 Accellent Revenue in Healthcare CMO Business (2019-2024)
11.1.5 Accellent Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Detail
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Healthcare CMO Introduction
11.2.4 Boehringer Ingelheim Revenue in Healthcare CMO Business (2019-2024)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Catalent
11.3.1 Catalent Company Detail
11.3.2 Catalent Business Overview
11.3.3 Catalent Healthcare CMO Introduction
11.3.4 Catalent Revenue in Healthcare CMO Business (2019-2024)
11.3.5 Catalent Recent Development
11.4 DSM
11.4.1 DSM Company Detail
11.4.2 DSM Business Overview
11.4.3 DSM Healthcare CMO Introduction
11.4.4 DSM Revenue in Healthcare CMO Business (2019-2024)
11.4.5 DSM Recent Development
11.5 Fareva
11.5.1 Fareva Company Detail
11.5.2 Fareva Business Overview
11.5.3 Fareva Healthcare CMO Introduction
11.5.4 Fareva Revenue in Healthcare CMO Business (2019-2024)
11.5.5 Fareva Recent Development
11.6 Greatbatch
11.6.1 Greatbatch Company Detail
11.6.2 Greatbatch Business Overview
11.6.3 Greatbatch Healthcare CMO Introduction
11.6.4 Greatbatch Revenue in Healthcare CMO Business (2019-2024)
11.6.5 Greatbatch Recent Development
11.7 Lonza
11.7.1 Lonza Company Detail
11.7.2 Lonza Business Overview
11.7.3 Lonza Healthcare CMO Introduction
11.7.4 Lonza Revenue in Healthcare CMO Business (2019-2024)
11.7.5 Lonza Recent Development
11.8 Patheon
11.8.1 Patheon Company Detail
11.8.2 Patheon Business Overview
11.8.3 Patheon Healthcare CMO Introduction
11.8.4 Patheon Revenue in Healthcare CMO Business (2019-2024)
11.8.5 Patheon Recent Development
11.9 Piramal
11.9.1 Piramal Company Detail
11.9.2 Piramal Business Overview
11.9.3 Piramal Healthcare CMO Introduction
11.9.4 Piramal Revenue in Healthcare CMO Business (2019-2024)
11.9.5 Piramal Recent Development
11.10 Tecomet
11.10.1 Tecomet Company Detail
11.10.2 Tecomet Business Overview
11.10.3 Tecomet Healthcare CMO Introduction
11.10.4 Tecomet Revenue in Healthcare CMO Business (2019-2024)
11.10.5 Tecomet Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’